|Bid||61.06 x 800|
|Ask||61.09 x 2200|
|Day's Range||59.85 - 61.11|
|52 Week Range||59.58 - 77.35|
|PE Ratio (TTM)||N/A|
|Beta (3Y Monthly)||1.28|
|Expense Ratio (net)||0.35%|
Healthcare took a hit recently on Johnson & Johnson news and a federal judge ruling. The rough trading also spread into the ETF world.
The Health Care Select Sector SPDR ETF ( XLV), the largest exchange-traded fund (ETF) tracking health care stocks, is up nearly 6% year to date, highlighting strength in the S&P 500's second largest sector weight.
DaVita (DVA) is a biotechnology company focused on the discovery, development, and commercialization of specialist medicines to cater to the medical needs in rare diseases and other specialized conditions. DaVita reported non-GAAP EPS of $1.15 on revenues of $2.9 billion, a 6.9% growth YoY (year-over-year) compared to $2.7 billion in the second quarter of 2017.
State Street Global Advisors announced that 29 additional SPDR ETFs with $33.56 billion in assets under management have been cross-listed on the International Quotation System (SIC) of the Mexican stock ...